Navigation Links
Schiffrin Barroway Topaz & Kessler, LLP and Janet Jenner & Suggs, LLC Comment on Conagra Advisory Regarding Pot Pies Linked to Salmonella Outbreak
Date:10/10/2007

Agriculture's Food Safety and Inspection Service, consumers should not eat the pot pies "until we are able to determine the source, products and potential production dates of contamination and to verify proper cooking instructions for these not-ready- to-eat products."

"This is a very unfortunate situation for consumers. If ConAgra can't guarantee safe food, it shouldn't be selling it. We encourage consumers to preserve the evidence of the store-bought product. ConAgra is advising consumers to throw away the product and just save the UPC seal. We disagree with ConAgra's advice; the contaminated product is important evidence and needs to be safely preserved," said Rob Jenner, partner with Janet Jenner & Suggs, LLC.

SCHIFFRIN BARROWAY TOPAZ & KESSLER, LLP and JANET, JENNER & SUGGS, LLC. have established a registry for victims of Salmonella poisoning to document their injuries and illnesses. If consumers purchased or ingested the ConAgra or Banquet Pot Pie products and are concerned that they have been exposed to Salmonella they can go to www. Salmonella-recall-registry.com and register

their complaints and/or injuries. Upon investigation, registered complaints of injury will be forwarded to the proper health authorities.

Salmonella poisoning can lead to symptoms that can appear 12 to 72 hours after infection which include diarrhea, fever and abdominal cramps. The illness usually lasts four to seven days. In severe cases, the infection may spread from the intestines to the blood and then to other sites in the body, sometimes causing death. Treatment includes antibiotics.

If you or anyone you know believes that you have contracted Salmonella as a result of consuming the pot pie products and want to discuss your rights, please contact either Schiffrin Barroway Topaz & Kessler, LLP (Tobias L. Millrood, Esq. or Hal J. Kleinman, Esq.) toll free at 1-888-348-6787 or 1-610- 822-0249 or via e-mail at mass
'/>"/>

SOURCE Schiffrin Barroway Topaz & Kessler, LLP; Janet Jenner &Suggs, LLC
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions
2. FDA Announces Change of Location Notice for Upcoming Advisory Committee Meeting
3. Media Advisory: ACC Updated Schedule
4. Nektar Threraputics Announces Phase 2a Clinical Results Regarding the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative Hospital-Acquired Pneumonia Presented at the Annual American Thoracic Society International Conference
5. Clinical Trial Data (Phase 2a) Regarding Inhaled Amikacin Will Be Presented at American Thoracic Society International Conference
6. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
7. Fragile X, Down Syndromes Linked to Faulty Brain Communication, Stanford Researcher Finds
8. Diabetes Linked to Higher Parkinsons Risk
9. West Nile Virus Screening and Diagnostics Technology Emerges In Step with North American Outbreak
Post Your Comments:
*Name:
*Comment:
*Email: